- 220 W Goodwin Suite B Pleasanton, TX 78064
- 525 Oak Centre Dr Suite 405 San Antonio, TX 78258
Skip to content GLP-1 based medications may help eligible patients manage their weight as part of a comprehensive treatment plan. At Healthy Aging SA, medication decisions are guided by your medical history, individual needs, and health goals.
Our approach looks beyond weight alone to consider body composition, metabolic health, and the importance of ongoing medical follow-up.
GLP-1 is a hormone involved in appetite and blood sugar regulation. Medications that act on this pathway may help eligible patients feel fuller and reduce hunger, supporting weight management alongside nutrition and physical activity changes.
Semaglutide acts on GLP-1 receptors. Trizepatide acts on both GIP and GLP-1 pathways. The appropriate medication, if any, depends on your clinical evaluation.
GLP-1 based medication may be considered for some adults with obesity or adults who are overweight and have certain weight-related health conditions.
Eligibility is not based on weight alone. Your provider will consider factors such as:
A consultation is needed to determine whether this approach is appropriate for you.
Discuss your health history, current medications, goals, and any relevant risks with your provider.
If medication is appropriate, your provider will discuss the available option and how it fits into your broader care plan.
SECA body composition analysis may provide additional insight into changes in body fat and lean muscle during weight management.
Monitoring allows your care team to review progress, discuss side effects, and determine whether adjustments are needed.
Weight alone does not show how much of your body weight comes from fat or lean muscle. This distinction can matter during a weight-management program.
Our broader approach considers body composition, nutrition, physical activity, and relevant health factors. The aim is to support informed decisions about your care, not simple track changes on the scale.
GLP-1 medications are not suitable for everyone. Side effects may include gastrointestinal symptoms and other serious complications. Semaglutide and tirzepatide carry boxed warnings about thyroid C-cell tumors and are contraindicated for people with a personal or family history of medullary thyroid carcinoma or MEN2.
Inform your provider about your medical conditions, medications, pregnancy plans, and any upcoming procedures involving anesthesia or deep sedation. Your provider can explain the risks and benefits for your situation. Individual results vary, and medication should be combined with appropriate nutrition, physical activity, and clinical follow-up.
No. Eligibility depends on your medical history, health conditions, medication risks, and the specific product being considered.
Weight loss can involve changes in both fat and lean tissue. Your provider can discuss ways to monitor body composition and support your individual health goals.
Far far away, behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts. Separated they live in Bookmarksgrove right at the coast
Follow-up may include reviewing your response to treatment, side effects, relevant health measures, and body composition when appropriate.
Optimized by Seraphinite Accelerator